Patents by Inventor Marna Williams

Marna Williams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic use of anti-CS1 antibodies
    Patent number: 8008450
    Abstract: The present invention is directed to antagonists of CS1 that bind to and neutralize at least one biological activity of CS1. The invention also includes a pharmaceutical composition comprising such antibodies or antigen-binding fragments thereof. The present invention also provides for a method of preventing or treating disease states, including autoimmune disorders and cancer, in a subject in need thereof, comprising administering into said subject an effective amount of such antagonists.
    Type: Grant
    Filed: November 2, 2009
    Date of Patent: August 30, 2011
    Assignee: Abbott Biotherapeutics Corp.
    Inventors: Marna Williams, J. Yun Tso, Nicholas F. Landolfi, Gao Liu
  • THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES
    Publication number: 20100168397
    Abstract: The present invention is directed to antagonists of CS1 that bind to and neutralize at least one biological activity of CS1. The invention also includes a pharmaceutical composition comprising such antibodies or antigen-binding fragments thereof. The present invention also provides for a method of preventing or treating disease states, including autoimmune disorders and cancer, in a subject in need thereof, comprising administering into said subject an effective amount of such antagonists.
    Type: Application
    Filed: November 2, 2009
    Publication date: July 1, 2010
    Applicant: Facet Biotech Corporation
    Inventors: Marna Williams, J. Yun Tso, Nicholas F. Landolfi, Gao Liu
  • Therapeutic use of anti-CS1 antibodies
    Patent number: 7709610
    Abstract: The present invention is directed to antagonists of CS1 that bind to and neutralize at least one biological activity of CS1. The invention also includes a pharmaceutical composition comprising such antibodies or antigen-binding fragments thereof. The present invention also provides for a method of preventing or treating disease states, including autoimmune disorders and cancer, in a subject in need thereof, comprising administering into said subject an effective amount of such antagonists.
    Type: Grant
    Filed: November 5, 2004
    Date of Patent: May 4, 2010
    Assignee: Facet Biotech Corporation
    Inventors: Marna Williams, J. Yun Tso, Nicholas F. Landolfi, David B. Powers, Gao Liu
  • THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES
    Publication number: 20090246852
    Abstract: The present invention is directed to antagonists of CS1 that bind to and neutralize at least one biological activity of CS1. The invention also includes a pharmaceutical composition comprising such antibodies or antigen-binding fragments thereof. The present invention also provides for a method of preventing or treating disease states, including autoimmune disorders and cancer, in a subject in need thereof, comprising administering into said subject an effective amount of such antagonists.
    Type: Application
    Filed: March 3, 2009
    Publication date: October 1, 2009
    Applicant: FACET BIOTECH CORPORATION
    Inventors: Marna Williams, J. Yun Tso, Nicholas F. Landolfi, David B. Powers, Robert B. DuBridge, Debbie Law, Gao Liu
  • THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES
    Publication number: 20090238827
    Abstract: The present invention is directed to antagonists of CS1 that bind to and neutralize at least one biological activity of CS1. The invention also includes a pharmaceutical composition comprising such antibodies or antigen-binding fragments thereof. The present invention also provides for a method of preventing or treating disease states, including autoimmune disorders and cancer, in a subject in need thereof, comprising administering into said subject an effective amount of such antagonists.
    Type: Application
    Filed: March 10, 2009
    Publication date: September 24, 2009
    Applicant: FACET BIOTECH CORPORATION
    Inventors: MARNA WILLIAMS, J. YUN TSO, NICHOLAS F. LANDOLFI
  • THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES
    Publication number: 20090238835
    Abstract: The present invention is directed to antagonists of CS1 that bind to and neutralize at least one biological activity of CS1. The invention also includes a pharmaceutical composition comprising such antibodies or antigen-binding fragments thereof. The present invention also provides for a method of preventing or treating disease states, including autoimmune disorders and cancer, in a subject in need thereof, comprising administering into said subject an effective amount of such antagonists.
    Type: Application
    Filed: March 10, 2009
    Publication date: September 24, 2009
    Applicant: Facet Biotech Corporation
    Inventors: Marna Williams, J. Yun Tso, Nicholas F. Landolfi
  • Therapeutic use of anti-CS1 antibodies
    Publication number: 20060024296
    Abstract: The present invention is directed to antagonists of CS1 that bind to and neutralize at least one biological activity of CS1. The invention also includes a pharmaceutical composition comprising such antibodies or antigen-binding fragments thereof. The present invention also provides for a method of preventing or treating disease states, including autoimmune disorders and cancer, in a subject in need thereof, comprising administering into said subject an effective amount of such antagonists.
    Type: Application
    Filed: November 5, 2004
    Publication date: February 2, 2006
    Applicant: Protein Design Labs, Inc.
    Inventors: Marna Williams, J. Tso, Nicholas Landolfi, David Powers, Robert DuBridge, Debbie Law, Gao Liu
  • Therapeutic use of anti-CS1 antibodies
    Publication number: 20050025763
    Abstract: The present invention is directed to antagonists of CS1 that bind to and neutralize at least one biological activity of CS1. The invention also includes a pharmaceutical composition comprising such antibodies or antigen-binding fragments thereof. The present invention also provides for a method of preventing or treating disease states, including autoimmune disorders and cancer, in a subject in need thereof, comprising administering into said subject an effective amount of such antagonists.
    Type: Application
    Filed: May 7, 2004
    Publication date: February 3, 2005
    Applicant: Protein Design Laboratories, Inc.
    Inventors: Marna Williams, J. Tso, Nicholas Landolfi